Algenex is a company founded in 2003 headquartered in Spain. Brouky records 2 investors associated with the company.
Algenex is a biotech company developing proprietary Baculovirus vector expression systems in insect cells to produce recombinant proteins for animal health, human health, diagnostics, and biocomponents.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.